Efficacy and Safety of Vildagliptin in Subjects With Impaired Glucose Tolerance

Clinical trial NCT00237250 · COMPLETED

Trial details

NCT number: NCT00237250
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prediabetic State

Start date: 2005-10-01
Primary completion: 2006-07-01
Enrollment: 171

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.